Grown Rogue International (GRUSF) Equity Income (2023 - 2025)
Grown Rogue International's (GRUSF) quarterly Equity Income came in at $2162.1 billion in Q3 2025, up 1778.38% year-on-year from $115.1 billion in Q3 2024, and up 1285716849.33% quarter-over-quarter from -$168162.0 in Q2 2025.
Grown Rogue International (GRUSF) Equity Income (2023 - 2025) Analysis & Trends
Grown Rogue International's Equity Income history runs 3 years deep, the most recent figure standing at $2162.1 billion for Q3 2025.
- On a quarterly basis, Equity Income rose 1778.38% year-over-year to $2162.1 billion in Q3 2025; TTM through Sep 2025 was $90.7 billion, a 21.22% decrease from a year earlier, with the FY2024 full-year figure at $3.1 million, changed N/A from the prior year.
- Equity Income rose to $2162.1 billion in Q3 2025 per GRUSF's latest filing, from -$168162.0 in the prior quarter.
- Across five years, Equity Income topped out at $2162.1 billion in Q3 2025 and bottomed at -$2071.4 billion in Q4 2024.
- The 3-year median for Equity Income is $400016.0 (2023), against an average of $22.9 billion.
- Across the five-year window, Equity Income slumped 517831363.15% in 2024 and jumped 1778.38% in 2025, its largest moves.
- Year by year, Equity Income stood at $400016.0 in 2023, then slumped by 517831363.15% to -$2071.4 billion in 2024, then soared by 204.38% to $2162.1 billion in 2025.
- Per Business Quant, the three latest GRUSF Equity Income figures stand at $2162.1 billion (Q3 2025), -$168162.0 (Q2 2025), and -$1.2 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | Grown Rogue International | 99.32 Mn | 85.61 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2,162.09 Bn |
| Jun 30, 2025 | -168,162.00 |
| Mar 31, 2025 | -1.17 Mn |
| Dec 31, 2024 | -2,071.41 Bn |
| Sep 30, 2024 | 115.10 Bn |
| Jun 30, 2024 | 485,081.78 |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2023 | 400,016.00 |
| Oct 31, 2023 | 95,220.05 |